Despite the mitigation of remodeling phenotypes, chronic lung diseases will certainly still require other treatments such as antibiotics, anti-inflammatories, and/or CFTR modulators (e.g., E/T/I) in the case of CF. This evidence concerns the gene CFTR and cystic fibrosis.